Confined placental mosaicism
| Confined placental mosaicism | |
|---|---|
| Synonyms | CPM |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Intrauterine growth restriction, Miscarriage |
| Complications | Fetal growth restriction, Preterm birth |
| Onset | Pregnancy |
| Duration | Gestation |
| Types | N/A |
| Causes | Chromosomal mosaicism |
| Risks | Advanced maternal age, Assisted reproductive technology |
| Diagnosis | Chorionic villus sampling, Amniocentesis |
| Differential diagnosis | True fetal mosaicism, Maternal cell contamination |
| Prevention | None |
| Treatment | Monitoring of fetal growth |
| Medication | N/A |
| Prognosis | Variable, depending on the extent of mosaicism |
| Frequency | 1-2% of pregnancies |
| Deaths | N/A |
Confined placental mosaicism (CPM) is a condition in which there are two or more different cell lines within the placenta, but not in the fetus itself. This phenomenon is detected through prenatal testing and can lead to various pregnancy outcomes, depending on the type and extent of the mosaicism. CPM is a complex topic within the field of genetics and obstetrics, and understanding its implications is crucial for managing affected pregnancies.
Types of Confined Placental Mosaicism[edit]
CPM is classified into three types based on the location of the abnormal cell lines:
- Type I: Abnormal cells are found only in the chorionic villi, the part of the placenta that is involved in nutrient and gas exchange between the mother and fetus.
- Type II: Abnormal cells are present in both the chorionic villi and the fetus.
- Type III: Abnormal cells are found in the chorionic villi and the placental bed (the maternal part of the placenta), but not in the fetus.
Causes and Detection[edit]
The exact cause of CPM is not fully understood, but it is believed to result from post-zygotic mutations or abnormal cell division after fertilization. CPM is typically detected through prenatal testing methods such as chorionic villus sampling (CVS) or amniocentesis. CVS, which involves taking a sample of tissue from the placenta, is more likely to detect CPM because it directly samples placental cells.
Implications of Confined Placental Mosaicism[edit]
The presence of CPM can have various implications for the pregnancy, including:
- Increased risk of intrauterine growth restriction (IUGR), where the fetus does not grow at the expected rate
- Increased risk of preeclampsia, a condition characterized by high blood pressure and damage to another organ system, often the liver and kidneys, in the mother
- Increased risk of miscarriage or stillbirth
However, it is important to note that many pregnancies with CPM proceed without complications and result in the delivery of a healthy baby.
Management and Counseling[edit]
Management of pregnancies affected by CPM involves increased monitoring, including more frequent ultrasounds to assess fetal growth and well-being. Counseling is an essential part of managing CPM, as it can be a source of significant anxiety for expectant parents. Genetic counseling can provide information about the potential implications of CPM and help parents understand the risks and management options.
Conclusion[edit]
Confined placental mosaicism is a condition that poses challenges for both healthcare providers and expectant parents. While it can be associated with adverse pregnancy outcomes, many pregnancies with CPM result in the birth of healthy infants. Ongoing research and improved prenatal testing methods continue to enhance our understanding of CPM and its implications for pregnancy management.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian